Dr. Peter A. Kaufman, MD
Medical Oncology (Medical Oncology Physician)
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (1983)
- Years since graduation
- 43
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 176
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1983Medical school: New York University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
NH license 8676 -
Hematology (Internal Medicine) Physician
NH license 8676 -
Hematology & Oncology Physician
NH license 8676
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Univ. of Vermont - Fletcher Allen Health Care Burlington, VT
- Northwestern Medical Center Inc Saint Albans, VT
- Porter Hospital Inc Middlebury, VT
- The University of Vermont Health Network-Alice Hy Malone, NY
Medical groups
- University of Vermont Medical Center Inc (1,208 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 176
- Services billed
- 614
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 331 | 141 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 28 | 21 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 27 | 25 |
| New patient office or other outpatient visit, 60-74 minutes | 25 | 25 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 24 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in Lebanon, NH | 207 |
| Anastrozole Other prescribers in Lebanon, NH | 43 |
| Tamoxifen Citrate Other prescribers in Lebanon, NH | 21 |
| Verzenio (abemaciclib) | 14 |
| Exemestane | 14 |
| Ondansetron Odt (ondansetron) Other prescribers in Lebanon, NH | 13 |
| Enoxaparin Sodium Other prescribers in Lebanon, NH | 12 |
| Everolimus | 11 |
| Ibrance (palbociclib) | 11 |
| Citalopram Hbr (citalopram hydrobromide) Other prescribers in Lebanon, NH | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 84 payments worth $79,237 in total to this clinician.
| Lilly USA, LLC | $61,152 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $14,148 |
| Pfizer Inc. | $1,900 |
| Merck Sharp & Dohme LLC | $1,074 |
| Daiichi Sankyo Inc. | $514 |
| Eli Lilly and Company | $450 |
| Compensation for services other than consulting (speaking, faculty) | $48,475 |
|---|---|
| Consulting Fee | $14,976 |
| Travel and Lodging | $14,528 |
| Food and Beverage | $1,257 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Dec 11, 2025 | Consulting Fee ENHERTU · Oncology | $4,100 |
| Lilly USA, LLC Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $4,050 |
| Lilly USA, LLC May 20, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC May 20, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,600 |
| Lilly USA, LLC Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| AstraZeneca Pharmaceuticals LP Jul 14, 2025 | Consulting Fee | $3,280 |
| Lilly USA, LLC Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,150 |
All 65 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Daiichi Sankyo Inc. Dec 23, 2025 | Consulting Fee Enhertu · ONCOLOGY | $514 |
| Lilly USA, LLC Dec 15, 2025 | Travel and Lodging travel to CHICAGO, IL | $184 |
| Lilly USA, LLC Dec 15, 2025 | Travel and Lodging travel to CHICAGO, IL | $130 |
| Lilly USA, LLC Dec 15, 2025 | Travel and Lodging travel to CHICAGO, IL | $32.01 |
| Lilly USA, LLC Dec 15, 2025 | Travel and Lodging travel to CHICAGO, IL | $28.00 |
| AstraZeneca Pharmaceuticals LP Dec 11, 2025 | Consulting Fee ENHERTU · Oncology | $4,100 |
| Lilly USA, LLC Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,600 |
| Lilly USA, LLC Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,150 |
| Lilly USA, LLC Nov 11, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $2,111 |
| Lilly USA, LLC Nov 11, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $313 |
| Lilly USA, LLC Nov 11, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $153 |
| Lilly USA, LLC Nov 11, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $149 |
| Pfizer Inc. Oct 31, 2025 | Compensation for services other than consulting (speaking, faculty) TUKYSA · ONCOLOGY · in-kind Company’s descriptionNo payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication. | $1,900 |
| Eli Lilly and Company Oct 31, 2025 | Consulting FeeCompany’s descriptionSERVICES TO SUPPORT RESEARCH RELATED ACTIVITIES | $450 |
| Lilly USA, LLC Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $1,125 |
| Lilly USA, LLC Oct 17, 2025 | Travel and Lodging VERZENIO · Oncology · travel to INDIANAPOLIS, IN | $130 |
| Lilly USA, LLC Oct 17, 2025 | Travel and Lodging VERZENIO · Oncology · travel to INDIANAPOLIS, IN | $34.00 |
| Lilly USA, LLC Oct 17, 2025 | Travel and Lodging VERZENIO · Oncology · travel to INDIANAPOLIS, IN | $22.50 |
| Merck Sharp & Dohme LLC Oct 16, 2025 | Travel and Lodging KEYTRUDA · ONCOLOGY · travel to Hanover, MA · in-kind | $1,074 |
| Lilly USA, LLC Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $900 |
| Lilly USA, LLC Jul 31, 2025 | Travel and Lodging VERZENIO · Oncology · travel to NEW YORK, NY | $130 |
| Lilly USA, LLC Jul 31, 2025 | Travel and Lodging VERZENIO · Oncology · travel to NEW YORK, NY | $42.00 |
| Lilly USA, LLC Jul 31, 2025 | Travel and Lodging VERZENIO · Oncology · travel to NEW YORK, NY | $20.00 |
| Lilly USA, LLC Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,150 |
| AstraZeneca Pharmaceuticals LP Jul 14, 2025 | Consulting Fee | $3,280 |
| Lilly USA, LLC Jul 12, 2025 | Travel and Lodging travel to NEW YORK, NY · in-kind | $614 |
| Lilly USA, LLC Jul 12, 2025 | Travel and Lodging travel to NEW YORK, NY · in-kind | $197 |
| Lilly USA, LLC Jul 12, 2025 | Travel and Lodging travel to NEW YORK, NY · in-kind | $136 |
| AstraZeneca Pharmaceuticals LP Jun 19, 2025 | Consulting Fee Truqap · Oncology Company’s descriptionResearch Related Service | $1,640 |
| AstraZeneca Pharmaceuticals LP Jun 19, 2025 | Consulting Fee | $343 |
| Lilly USA, LLC Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,150 |
| Lilly USA, LLC Jun 4, 2025 | Travel and Lodging travel to SKOWHEGAN, ME · in-kind | $694 |
| Lilly USA, LLC Jun 4, 2025 | Travel and Lodging travel to SKOWHEGAN, ME · in-kind | $387 |
| Lilly USA, LLC Jun 4, 2025 | Travel and Lodging travel to SKOWHEGAN, ME · in-kind | $168 |
| Lilly USA, LLC Jun 4, 2025 | Travel and Lodging travel to SKOWHEGAN, ME · in-kind | $154 |
| Lilly USA, LLC Jun 2, 2025 | Travel and Lodging VERZENIO · Oncology · travel to BAYSIDE, NY | $65.80 |
| Lilly USA, LLC Jun 2, 2025 | Travel and Lodging VERZENIO · Oncology · travel to BAYSIDE, NY | $10.00 |
| Lilly USA, LLC May 30, 2025 | Travel and Lodging VERZENIO · Oncology · travel to BROOKLYN, NY | $65.80 |
| Lilly USA, LLC May 30, 2025 | Travel and Lodging VERZENIO · Oncology · travel to BROOKLYN, NY | $48.00 |
| Lilly USA, LLC May 30, 2025 | Travel and Lodging VERZENIO · Oncology · travel to BROOKLYN, NY | $10.00 |
| Lilly USA, LLC May 20, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC May 20, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC May 20, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,150 |
| Lilly USA, LLC May 20, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,150 |
| Lilly USA, LLC May 15, 2025 | Travel and Lodging travel to BAYSIDE, NY · in-kind | $1,958 |
| Lilly USA, LLC May 15, 2025 | Travel and Lodging travel to BAYSIDE, NY · in-kind | $626 |
| Lilly USA, LLC May 15, 2025 | Travel and Lodging travel to BAYSIDE, NY · in-kind | $513 |
| Lilly USA, LLC May 15, 2025 | Travel and Lodging travel to BAYSIDE, NY · in-kind | $136 |
| Lilly USA, LLC May 15, 2025 | Travel and Lodging travel to BAYSIDE, NY · in-kind | $136 |
| AstraZeneca Pharmaceuticals LP Apr 15, 2025 | Consulting Fee | $1,640 |
| Lilly USA, LLC Apr 7, 2025 | Travel and Lodging VERZENIO · Oncology · travel to JERSEY CITY, NJ | $15.00 |
| Lilly USA, LLC Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $4,050 |
| Lilly USA, LLC Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,600 |
| Lilly USA, LLC Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) VERZENIO · Oncology | $3,150 |
| Lilly USA, LLC Feb 25, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $1,199 |
| Lilly USA, LLC Feb 25, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $1,129 |
| Lilly USA, LLC Feb 25, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $485 |
| Lilly USA, LLC Feb 25, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $480 |
| Lilly USA, LLC Feb 25, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $475 |
| Lilly USA, LLC Feb 25, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $136 |
| Lilly USA, LLC Feb 25, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $136 |
| AstraZeneca Pharmaceuticals LP Feb 21, 2025 | Consulting Fee | $1,640 |
| AstraZeneca Pharmaceuticals LP Feb 11, 2025 | Consulting Fee | $1,370 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 1 companies. The companies reported $107,577 in research payments for these studies, mostly to the institutions running them.
- A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Eli Lilly and Company · Active, not recruiting · NCT04188548 - A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
Eli Lilly and Company · Active, not recruiting · NCT04975308 - Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Eli Lilly and Company · Active, not recruiting · NCT03155997
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.